Reason for request
Renewal of inclusion on the list of medicines refundable by National Health Insurance and Re-assessment of the actual benefit following the Transparency Committee conclusions in its opinions of 26 November 2008 and reiterated in its opinion of 21 September 2011.
Clinical Benefit
| Insufficient |
The actual benefit of CHONDROSULF 400 mg capsules and granules is insufficient to justify reimbursement by National Insurance. |
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
7zUc4RHRWpSqsMMN
